-
Mashup Score: 0Visual abstract | Phase III trial of Iomab-B versus conventional conditioning pre-HSCT in patients with R/R AML (SIERRA) - 1 year(s) ago
This visual abstract highlights the key results from the phase III SIERRA trial of Iomab-B prior to HSCT compared with conventional care.
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Real-World Analysis Compares Inpatient and Outpatient CAR T-Cell Therapy in MCL and Follicular Lymphoma - 1 year(s) ago
Inpatient infusion was linked with greater comorbidity burden and increased likelihood of adverse effects in patients with follicular lymphoma who received CAR T-cell therapy, but not in those with mantle cell lymphoma.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Siltuximab led to the complete resolution of cytokine release syndrome in 5 out of 6 patients, with a median time to complete response within 1 hour.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Real-World Analysis Compares Inpatient and Outpatient CAR T-Cell Therapy in MCL and Follicular Lymphoma - 1 year(s) ago
Inpatient infusion was linked with greater comorbidity burden and increased likelihood of adverse effects in patients with follicular lymphoma who received CAR T-cell therapy, but not in those with mantle cell lymphoma.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
In an interview with Targeted Oncology, Yago Nieto, MD, PhD, discussed the full data from the phase 2 trial of panobinostat, gemcitabine, busulfan, and melphalan for patients with high-risk, relapsed/refractory myeloma.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Educational Interventions Prove Beneficial for Caregivers of Pediatric Patients Receiving HSCT - 1 year(s) ago
Nurse researchers sought to improve the communication between the hematopoietic stem cell transplantation care team and pediatric patient caregivers.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Muhammad Umair Mushtaq, MD, University of Kansas Medical Center, Westwood, KS, shares the results of a single-center retrospective study comparing…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Real-World Analysis Evaluates Inpatient Vs Outpatient CAR T-Cell Therapy Administration in MCL and FL - 1 year(s) ago
A real-world analysis exploring the outcomes of inpatient vs outpatient administration of CAR T-cell therapy in patients with mantle cell lymphoma and follicular lymphoma demonstrated both similarities and some differences between the 2 patient populations.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1First-line ASCT Consolidation Confers Real-world Survival Benefit in Mantle Cell Lymphoma - 1 year(s) ago
Consolidative autologous stem cell transplant was associated with a statistically significant lower overall mortality risk and higher overall survival probability in patients with mantle cell lymphoma vs those who did not receive consolidation.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 12023 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - 1 year(s) ago
Evaluations and Credits The 2023 Tandem Meetings will offer Continuing Medical Education (CME) credit, Continuing Pharmacy Education (CPE) Credit and Nursing Continuing Professional Development (NCPD) Credit. Continuing Medical Education (CME) will be available once evaluations are completed through this online program. CME Evaluations must be completed by March…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
📊 At #Tandem23, Sergio Giralt presented data from the SIERRA trial of Iomab-B conditioning prior to HSCT in patients with R/R AML. See our entire visual abstract here 👉 https://t.co/Ug7cq9CgY9. #leusm https://t.co/qI9Xy9plxz